Daisuke Tomita
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Diagnostic performance of HScore for macrophage activation syndrome complicating Still's disease in adults: a multicentre case-control study.
Journal: Rheumatology (Oxford, England)
Published: March 28, 2026
Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score-matched real-world study accounting for poor prognostic factors.
Journal: Annals of the rheumatic diseases
Published: February 08, 2026
Comparative effectiveness and safety of sarilumab vs JAK inhibitors in late- and younger-onset rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: December 21, 2025
Exploratory comparison of diffusion-weighted whole-body imaging with background body signal suppression and 18F-FDG PET/CT for assessing disease activity in large-vessel vasculitis.
Journal: Modern rheumatology
Published: October 17, 2025
Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: October 06, 2025
Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): An interventional, multicenter, open-label, single-arm clinical trial with clinical, ultrasound and biomarker assessments.
Journal: Drug discoveries & therapeutics
Published: August 24, 2025
Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study.
Journal: Rheumatology (Oxford, England)
Published: April 22, 2025
Stepwise dose reduction and discontinuation of bDMARD in rheumatoid arthritis: a prospective cohort study of flare-free population, flares, and predictive markers.
Journal: Arthritis research & therapy
Published: April 20, 2025
Utility of the GerdQ questionnaire in detecting gastroesophageal symptoms with RA patients.
Journal: BMC rheumatology
Published: October 03, 2024
U-KIM-1 as a predictor of treatment response in lupus nephritis.
Journal: Lupus
Published: October 28, 2022
Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: Adjusted with propensity score matching.
Journal: Modern rheumatology
Published: March 11, 2022
Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Journal: Frontiers in immunology
Published: July 30, 2021
Last Updated: 09/26/2026